Literature DB >> 15014688

Valproate in Bipolar Disorder: Case Examples From a Family Practice.

J Sloan Manning1.   

Abstract

Valproate, an antiepileptic drug, is useful in the management of various nonepileptic disorders. It is an effective and generally well-tolerated medication for the treatment of bipolar disorder and has been approved by the Food and Drug Administration for use in manic states. Studies also suggest that it is effective in other bipolar spectrum illnesses. This report describes 2 clinical cases of DSM-IV bipolar disorder where valproate provided robust, sustained relief of mood symptoms. In the first case, valproate was chosen for initial therapy in a bipolar patient suffering from a mixture of hypomanic and depressive symptoms. In the second case, valproate replaced lithium in the management of a patient with an incomplete response to lithium plus an antidepressant. This report addresses relevant clinical issues and includes a brief review of the clinical pharmacology of valproate.

Entities:  

Year:  1999        PMID: 15014688      PMCID: PMC181065          DOI: 10.4088/pcc.v01n0303

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  8 in total

1.  [Neuropsychotropic action of a new anti-epileptic agent: depamide].

Authors:  P A Lambert; G Carraz; S Borselli; S Carbel
Journal:  Ann Med Psychol (Paris)       Date:  1966-05       Impact factor: 0.380

2.  On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally.

Authors:  J S Manning; R F Haykal; P D Connor; H S Akiskal
Journal:  Compr Psychiatry       Date:  1997 Mar-Apr       Impact factor: 3.735

3.  Sodium valproate: its use in primary psychiatric disorders.

Authors:  S L McElroy; P E Keck; H G Pope
Journal:  J Clin Psychopharmacol       Date:  1987-02       Impact factor: 3.153

Review 4.  An update on the diagnosis and treatment of mania in bipolar disorder.

Authors:  S F Werder
Journal:  Am Fam Physician       Date:  1995-04       Impact factor: 3.292

5.  Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.

Authors:  C L Bowden; A M Brugger; A C Swann; J R Calabrese; P G Janicak; F Petty; S C Dilsaver; J M Davis; A J Rush; J G Small
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272

Review 6.  Valproate in psychiatric disorders: literature review and clinical guidelines.

Authors:  S L McElroy; P E Keck; H G Pope; J I Hudson
Journal:  J Clin Psychiatry       Date:  1989-03       Impact factor: 4.384

Review 7.  Valproate use in acute mania and bipolar disorder: an international perspective.

Authors:  J Fawcett
Journal:  J Clin Psychiatry       Date:  1989-03       Impact factor: 4.384

Review 8.  Mixed or dysphoric manic states: psychopathology and treatment.

Authors:  A C Swann
Journal:  J Clin Psychiatry       Date:  1995       Impact factor: 4.384

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.